Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Accenture
UBS
Farmers Insurance
Queensland Health
Boehringer Ingelheim
Chinese Patent Office
US Army
Covington

Generated: December 17, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR HYALURONIDASE RECOMBINANT HUMAN

« Back to Dashboard

Clinical Trials for Hyaluronidase Recombinant Human

Trial ID Title Status Sponsor Phase Summary
NCT00000493 Multicenter Investigation of Limitation of Infarct Size (MILIS) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 To assess the ability of two separate therapeutic interventions, propranolol and hyaluronidase, to limit the ultimate size of an acute myocardial infarction. A secondary objective was to assess the influence of these therapies upon ventricular function and morbidity following myocardial infarction.
NCT00198419 Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase) Completed Bausch & Lomb Incorporated Phase 1 The objective of this study was to rule out a greater than 10% incidence of hypersensitivity to Vitrase following a single intradermal injection of 3 USP units Vitrase. Less than or equal to 10% hypersensitivity response was considered acceptable.
NCT00198458 Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase) Completed Bausch & Lomb Incorporated Phase 1 The objective of this study was to rule out a greater than 10% incidence of hypersensitivity to Vitrase following a single intradermal injection of 3 USP units Vitrase. Less than or equal to a 10% hypersensitivity response was considered acceptable.
NCT00198471 Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment Completed Bausch & Lomb Incorporated Phase 2 The purpose of this study is to assess the efficacy of intravitreous injections of Vitrase to induce posterior vitreous detachment(PVD) in subjects with moderate to severe non-proliferative diabetic retinopathy.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Hyaluronidase Recombinant Human

Condition Name

Condition Name for Hyaluronidase Recombinant Human
Intervention Trials
Type 1 Diabetes Mellitus 5
Dehydration 5
Healthy 5
Diabetic Retinopathy 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Hyaluronidase Recombinant Human
Intervention Trials
Diabetes Mellitus 11
Diabetes Mellitus, Type 1 7
Dehydration 5
Adenocarcinoma 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Hyaluronidase Recombinant Human

Trials by Country

Trials by Country for Hyaluronidase Recombinant Human
Location Trials
United States 252
Canada 12
Brazil 11
France 11
United Kingdom 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Hyaluronidase Recombinant Human
Location Trials
California 29
Texas 14
New York 13
Michigan 12
Washington 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Hyaluronidase Recombinant Human

Clinical Trial Phase

Clinical Trial Phase for Hyaluronidase Recombinant Human
Clinical Trial Phase Trials
Phase 4 11
Phase 3 9
Phase 2/Phase 3 1
[disabled in preview] 18
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Hyaluronidase Recombinant Human
Clinical Trial Phase Trials
Completed 38
Unknown status 8
Recruiting 8
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Hyaluronidase Recombinant Human

Sponsor Name

Sponsor Name for Hyaluronidase Recombinant Human
Sponsor Trials
Halozyme Therapeutics 33
Baxter Healthcare Corporation 7
Bausch & Lomb Incorporated 6
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Hyaluronidase Recombinant Human
Sponsor Trials
Industry 53
Other 40
NIH 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Argus Health
Citi
Federal Trade Commission
US Army
Chubb
McKesson
Medtronic
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.